NEWMarkets

Vivos (VIVK) CEO Michael Korenko Buys $11,420 in Stock

Published on 7/15/2026

#VIVK#InsiderBuying#Markets
Vivos (VIVK) CEO Michael Korenko Buys $11,420 in Stock

AI Summary

Summarized by AI from the source below

Michael Korenko, CEO of Vivos Therapeutics (VIVK), purchased $11,420 worth of company stock. This acquisition underscores Korenko's confidence in the company's future performance. Such insider transactions can influence market perceptions and potentially affect stock price behavior. Investors often monitor insider buying activity as a signal of management's belief in the company's prospects.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

S&P/TSX Composite Up in Late-Morning Trading Amid U.S. Gains
Markets

S&P/TSX Composite Up in Late-Morning Trading Amid U.S. Gains

Jul 15

Stock Market Today: Dow Rises 0.5% Amid Lower Inflation Data
Markets

Stock Market Today: Dow Rises 0.5% Amid Lower Inflation Data

Jul 15

AtaiBeckley (ATAI) Included in Russell Indices Effective June 29
Markets

AtaiBeckley (ATAI) Included in Russell Indices Effective June 29

Jul 15

Sharplink (SBET) Stock Repurchase and Ether Holdings Update
Markets

Sharplink (SBET) Stock Repurchase and Ether Holdings Update

Jul 15